Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasms of Urinary Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT02632409
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 709
Testing effectiveness (Phase 2)UnknownNCT00005958
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Amgen
Testing effectiveness (Phase 2)Study completedNCT04068896
What this trial is testing

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

Who this might be right for
Pancreatic CancerMetastatic Castration-resistant Prostate CancerBladder Cancer+8 more
NGM Biopharmaceuticals, Inc 89
Not applicableStudy completedNCT00957424
What this trial is testing

Acceptability of Less Harmful Alternatives to Cigarettes

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 67
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Post-approval studies (Phase 4)Study completedNCT01554865
What this trial is testing

Effects of Diet-induced Weight Loss in Obese Men

Who this might be right for
Sexual DysfunctionEndothelial DysfunctionQuality of Life+1 more
Changi General Hospital 70
Early research (Phase 1)Study completedNCT00019630
What this trial is testing

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Soft Tissue SarcomaChildhood Liver CancerBone Cancer+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT05231746
What this trial is testing

HSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

Who this might be right for
Advanced Solid Tumor
STCube, Inc. 47
Not applicableStudy completedNCT01365182
What this trial is testing

Improving Urinary Continence and Quality of Life in Prostate Cancer Patients

Who this might be right for
Urinary Incontinence
Case Western Reserve University 279
Not applicableWithdrawnNCT05415696
What this trial is testing

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Who this might be right for
Prostate Cancer
Stanford University
Testing effectiveness (Phase 2)Study completedNCT04892342
What this trial is testing

Study of ESG401 in Adults With Solid Tumors

Who this might be right for
Neoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more
Shanghai Escugen Biotechnology Co., Ltd 156
Not applicableStudy completedNCT04535921
What this trial is testing

Fear of Cancer Recurrence in Genitourinary Cancer

Who this might be right for
Fear of Cancer RecurrenceProstate CancerRenal Cell Cancer+2 more
Ludwig-Maximilians - University of Munich 500
Testing effectiveness (Phase 2)Study completedNCT02109328
What this trial is testing

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Who this might be right for
Bladder CancerTransitional Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableLooking for participantsNCT06357416
What this trial is testing

The Man Van Project

Who this might be right for
Prostate CancerUrologic CancerUrologic Diseases+8 more
Royal Marsden NHS Foundation Trust 4,000
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Next Page